Market Newsdesk

SAN JOSE, Calif., and VENRAY, The Netherlands, Sept. 20, 2021 /PRNewswire/ — Flex (NASDAQ: FLEX) today announced it is the winner of the European Lenovo Logistics Excellence Award, its third consecutive award in this category. The award was presented to Flex at the recent Lenovo Global Logistics Suppliers Conference FY21/22 in recognition of sustained high performance and flexibility despite growing complexity and significant increases in volumes.

Flex supports Lenovo PC & Smart Devices, Mobile and Data Center business groups and offers a number of value-added fulfilment services including ocean and rail transport, inventory management, and logistics support.

Flex also manages Lenovo service parts and last mile distribution to Lenovo customers in Europe.

Speaking at the virtual Lenovo Supplier Conference, Lenovo Logistics Director EMEA, Dick van Beek said, “In what was an extraordinary year for logistics, Flex delivered outstanding support to the Lenovo EMEA Region. As more people worked from home, we saw increased demand for our products combined with increased complexity in getting those products to customers. Flex adapted without missing a beat, and are deserving winners of the Logistics Excellence Award.”

Commenting on the award, Pat Ring, Senior Vice President and General Manager for Flex Global Services and Solutions said, “We are truly honored to receive this award from Lenovo, who are leaders in supply chain execution, for the third consecutive year and I am very proud of the commitment and motivation of our team in a highly volatile and dynamic environment.  Collaboration, communication and trust are the characteristics that enabled us to maintain high levels of service delivery despite the many challenges of the last year.”

About Flex

Flex (Reg. No. 199002645H) is the manufacturing partner of choice that helps a diverse customer base design and build products that improve the world. Through the collective strength of a global workforce across 30 countries and responsible, sustainable operations, Flex delivers technology innovation, supply chain, and manufacturing solutions to diverse industries and end markets.

Media & Press
Mark Plungy
Director, Corporate Integrated Communications
(408) 442-1691
[email protected]

Investors & Analysts
David Rubin
Vice President, Investor Relations
(408) 577-4632
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/flex-receives-3rd-consecutive-european-lenovo-logistics-excellence-award-301379936.html

SOURCE Flex

MOUNTAIN VIEW, Calif., Sept. 20, 2021 /PRNewswire/ —

Highlights of this Announcement:

• Synopsys ARC 128-bit VPX2 and 256-bit VPX3 DSP IP are based on same advanced VLIW/SIMD architecture as higher performance 512-bit VPX5, providing greater flexibility for specific application requirements
• Portfolio includes safety-enhanced implementations that meet random fault detection and systematic functional safety development flow requirements for full ISO 26262 compliance up to ASIL D
• MetaWare Development Toolkit with C/C++ compiler and associated libraries supports vector length-agnostic programming to accelerate code development and portability
• Attend the ARC Processor Virtual Summit on September 21 – 22, 2021, to learn more about the new ARC VPX DSPs and hear about the latest technologies and trends in processor IP

To address the broader range of power, performance and area (PPA) demands of embedded applications, Synopsys, Inc. (Nasdaq: SNPS) today announced it has expanded its DesignWare® ARC® Processor IP portfolio with new 128-bit ARC VPX2 and 256-bit ARC VPX3 DSP Processors. Based on the same VLIW/SIMD architecture as the company’s higher performance 512-bit ARC VPX5 DSP processor, the new additions deliver up to two-thirds lower power and area. The ARC VPX DSP IP family now provides greater flexibility for designers to optimize their designs based on the unique power, performance and area (PPA) requirements of embedded workloads such as IoT sensor fusion, radar and LiDAR processing, engine control, voice/speech recognition, natural language processing and other edge AI applications.

“AI-enabled devices have an increasing need for specialized processors that can handle a variety of DSP and machine learning workloads with a high degree of energy efficiency,” said CL Chen, COO at Neuchips, a leading AI domain specific compute solutions startup in Taiwan. “By expanding the ARC VPX processor family to support a range of vector lengths, Synopsys enables designers targeting a broader set of applications to implement high-performance signal processing in their designs.”

“By expanding the ARC DSP processor portfolio with support for smaller vectors, Synopsys is enabling signal processing and AI in size, power, and thermally-constrained systems,” said Jim McGregor, Principal Analyst at Tirias Research. “In addition, the ultra-high floating-point performance and functional safety compliance of the VPX processors make them especially well-suited for the growing number of IoT applications like automotive, medical systems, and industrial automation. Synopsys’ ARC processors have been used by over 250 customers worldwide who collectively ship more than 2.5 billion ARC-based chips annually.”

Scalable and Highly Configurable DSP Processors

The smaller vector-length ARC VPX2 and VPX3 DSP processors, optimized for highly parallel processing with minimal energy and area consumption, are available in single- or dual-core configurations to address a broad range of application requirements. Each VPX core contains a scalar execution unit and multiple vector units that support 8-bit, 16-bit and 32-bit SIMD computations. The VPX DSPs support half-, single-, and double-precision floating point formats, and up to three floating point pipelines are available in each VPX core. The unique hardware acceleration for special math functions used in linear and non-linear algebra functions deliver high-precision results. The new VPX DSPs include enhancements to the instruction set architecture (ISA) and load/store bandwidth to deliver up to twice the performance of existing offerings for common DSP functions such as fast Fourier transforms (FFTs). In addition, the safety-enhanced ARC VPX2FS and VPX3FS integrate hardware safety features including error correction code (ECC) protection for memories and interfaces, safety monitors and lockstep mechanisms that help designers achieve the most stringent levels of ISO 26262 ASIL B, ASIL C and ASIL D functional safety compliance.

Comprehensive Software Development Environment

Like all Synopsys ARC processors, the VPX2 and VPX3 processors are supported by the Synopsys ARC MetaWare Development Toolkit, which provides a vector length-agnostic software programming model specifically optimized for the VPX hardware architecture. The MetaWare compiler’s auto-vectorization feature transforms sequential code into vector operations for maximum throughput. Together with a robust set of software libraries that include DSP, machine learning and linear algebra functions, the MetaWare Development Toolkit delivers a comprehensive programming environment that accelerates time to optimum results and simplifies software portability.

“We continue to build on our industry leadership by expanding the DesignWare ARC processor family with the latest VPX DSP processors,” said John Koeter, senior vice president of marketing and strategy for IP at Synopsys. “Synopsys provides designers with a full range of scalable, software-compatible DSP IP solutions that address the varying performance, power and area requirements across a chip family.”  

The broad Synopsys DesignWare IP portfolio includes logic libraries, embedded memories, IOs, PVT monitors, embedded test, analog IP, interface IP, security IP, embedded processors and subsystems. To accelerate prototyping, software development and integration of IP into SoCs, the company’s IP Accelerated initiative offers IP prototyping kits, IP software development kits and IP subsystems. Synopsys’ extensive investment in IP quality and comprehensive technical support enable designers to reduce integration risk and accelerate time-to-market. For more information, please visit https://www.synopsys.com/designware.

Availability

• The Synopsys DesignWare ARC VPX2 and VPX3 DSP Processor IP is scheduled to be available to lead customers in calendar Q4 2021.
• The Synopsys DesignWare ARC VPX2FS and VPX3FS Processor IP is scheduled to be available to lead customers in calendar Q1 2022.

Additional information can be found here.

ARC Processor Virtual Summit,

Sept 21-22, 2021

The ARC Processor Virtual Summit will deliver all the practical knowledge you need to meet your unique PPA requirements. The summit includes a special keynote, TinyML and Efficient Deep Learning from Song Han, assistant professor of EECS at MIT. Han will teach TinyML techniques to help you address artificial intelligence’s (AI’s) extraordinary requirements for data, computation, and power in a way that will make your designs greener, faster, more efficient, and sustainable.  Register to attend the event.

About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is the Silicon to Software™ partner for innovative companies developing the electronic products and software applications we rely on every day. As an S&P 500 company, Synopsys has a long history of being a global leader in electronic design automation (EDA) and semiconductor IP and offers the industry’s broadest portfolio of application security testing tools and services. Whether you’re a system-on-chip (SoC) designer creating advanced semiconductors, or a software developer writing more secure, high-quality code, Synopsys has the solutions needed to deliver innovative products. Learn more at www.synopsys.com.  

Editorial Contact:                                                                

Simone Souza

Synopsys, Inc.
650-584-6454
[email protected] 

View original content:https://www.prnewswire.com/news-releases/synopsys-advances-processor-ip-leadership-with-new-arc-dsp-ip-solutions-for-low-power-embedded-socs-301380301.html

SOURCE Synopsys, Inc.

NEW YORK, Sept. 20, 2021 /PRNewswire/ — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that the Company secured an early equity interest in tele-health company, Kerna Health (https://kernahealth.com).

Kerna Health is a next-generation digital health monitoring and virtual care company that is exhibiting growing momentum. The Company is fast developing a large backlog of shared revenue contracts, typically executed with partner/customers like multi-hospital chains and smaller hospitals, LTC (long term care) companies, large physician practices, ACO’s, and other major healthcare players, who are looking for better patient outcomes, large untapped revenues, and lower healthcare costs through such contracts, by onboarding their large patient populations on Kerna’s technology platform for remote patient monitoring of chronic illness. The Company’s backlog of such executed contracts is already at the $25 million mark in pro-forma shareable revenues, and with additional in-process contracts could grow to $50 million in the short term, and $400 million after that – evidence of a clear growth trajectory.

Kerna utilizes advanced software and online technologies, coupled with at-home health and physiologic monitoring devices like glucose meters, blood pressure cuffs, weight scales, and others, to better manage chronic illness, such as cardiac diseases, diabetes, and long-term wounds.

The technology platform gathers daily readings securely transmitted by devices used by patients, at home, in long term or transitional care facilities, or hospitals, and based on programmed criteria sends alerts to a patient’s primary and specialty care providers, as well as to the patients themselves or their families.  

In addition to the physiologic data monitoring associated with such diseases, Kerna’s platform also offers complementary health support services that utilize expert content and behavior changing recommendations and initiatives, under the direction of social workers and other non-clinical professionals using relevant Kerna digital technologies. An example is the behavioral health integration program designed, paid for, and recommended by CMS/Medicare. (https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/Downloads/BehavioralHealthIntegration.pdf).

Anthony Hayes, CEO of AIkido stated, “After COVID, the use of telemedicine and digital health services, such as those provided by Kerna, has sky-rocketed. This is also evidenced by the brand-name customers, revenue contracts backlog that the Company is onboarding to recognize as recurring revenues during the coming year for itself and its healthcare provider partner/customers, and by the growing pipeline for Kerna’s technology platform. We are excited for Kerna’s future and glad to be a part of it, especially as their traction could lead toward a potential IPO. This transaction fits perfectly with our growth strategy as we continue our momentum with a clear focus on monetization and liquidity events for our shareholders. Additionally, we are in a number of additional advanced business development discussions that we are aiming to close in the near future.”

Crystal Lore, Chief Revenue Officer of Kerna noted, “First, we are honored and excited to be associated with the AIkido Pharma team. In addition to investment benefits, we believe that the health data accumulated by Kerna could also be a basis for collaboration with AIkido. I have been a business and revenue development professional working in the Medicare space for over 20 years for companies that we grew fast enough for multi-billion dollar exits – even years before now when the space has heated up as it has. That experience simply doesn’t compare with the current market excitement, focus on digital health and remote patient monitoring, and customer demand for online health monitoring technologies and services we have at Kerna. Post-COVID and the new-found focus on tele-health, there is a market push for remote patient monitoring solutions by Medicare, on the one hand, and a market pull by healthcare providers, on the other. Hospitals, long term care facilities, and Doctor practices, see large untapped incremental revenues by becoming Kerna customers/partners, while also providing better health outcomes to their patients. The demand is such that we are already generating a contract backlog of annual remote patient monitoring revenues with these healthcare partner/customers that could qualify for a Kerna IPO in the very near term.”

About AIkido Pharma Inc.

AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology Company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company’s platform consists of patented technology from leading universities and researchers, and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and University of Maryland at Baltimore. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer and prostate cancer. We are constantly seeking to grow our pipeline to treat unmet medical needs in oncology. The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus.

Forward-Looking Statements

Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company’s filings with the SEC, not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Investor Relations:   

Hayden IR

Brett Maas, Managing Partner
Phone: (646) 536-7331
Email: [email protected] 
www.haydenir.com

AIkido Pharma Inc.
Phone: 212-745-1373
Email: [email protected]
www.aikidopharma.com

Kerna Health

Crystal Lore, Chief Revenue Officer
Phone: 772-607-1353
Email: [email protected] 
www.kernahealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/aikido-pharma-secures-interest-in-growing-tele-health-company-301380265.html

SOURCE AIkido Pharma Inc.

DUBLIN, Ohio, Sept. 20, 2021 /PRNewswire/ — Cardinal Health (NYSE: CAH) today announced it has established a goal to reduce Scope 1 and Scope 2 greenhouse gas (GHG) emissions 50% by 2030.

“We deliver products and services to improve the lives of people every day and our approach to doing business must help protect our planet for future generations,” said Mike Kaufmann, CEO at Cardinal Health. “We’re operating sustainably and responsibly so we can care for our people and our planet – today, and tomorrow.”

Cardinal Health’s announced Scope 1 and 2 targets align with what the latest climate science deems necessary to meet the goals of the Paris Agreement – limiting global warming to well-below 2°C above pre-industrial levels and pursuing efforts to limit warming to 1.5°C. Further, the company is assessing its Scope 3 emissions and working towards validation of a comprehensive Scope 1, 2 and 3 science-based target by the Science-Based Targets initiative (SBTi).

“As a global company, we can help create a healthier, more sustainable world,” said Sarah Wills, Chief Corporate Affairs Officer at Cardinal Health. “I’m proud of the significant steps Cardinal Health is taking in setting and reporting on our enterprise GHG targets, as well as reducing our impact on the environment.”

FY21 Corporate Citizenship Report
This enterprise GHG announcement is associated with the release of Cardinal Health’s annual Corporate Citizenship Report today, which highlights certain of the company’s ESG priorities and ongoing focus on creating a diverse, inclusive workforce.

Additional FY21 environmental highlights include:

• In 2021, Cardinal Health also announced it will use renewable energy to fully power its global headquarters and its National Logistics Center in Central Ohio, beginning in early 2022. Cardinal Health was one of Central Ohio’s three founding partners of Smart Columbus Energy, an initiative of Smart Columbus designed to support the decarbonization of large businesses in the region, which pools customers’ energy demands and allows procurement energy from Ohio-based wind and solar projects.
• Continued expansion of the company’s Total Waste Management (TWM) initiative, previously initiated in FY20 to simplify and standardize waste management. In FY21, Cardinal Health extended TWM throughout its pharmaceutical distribution, specialty and global logistics businesses, and as a result:
• Increased landfill avoidance by 750 tons – about as much as four locomotives.
• Increased use of Waste-to-Energy, generating 412k kWh, enough to fuel 39 homes for a year.
• Published a report using the recommendations of the Task Force on Climate-related Financial Disclosures (TCFD) as a guide. Read the Cardinal Health TCFD report here.

Representation goals for 2030



As previously announced, Cardinal Health has set goals of increasing leadership representation of women and racial and ethnic populations among its workforce by 2030:

• Globally, increased representation of women at the manager level and above to 48% (up from 40%).
• In the U.S., increased representation of African American and Black employees at the manager level and above to 11% (up from 5%).
• In the U.S., increased representation of Asian, Latinx, Indigenous and all other ethnically diverse groups at the manager level and above to 23% (up from 17%).

Cardinal Health is continually refining its recruiting, development, succession planning and retention practices to ensure equitable access and opportunity. For more information on these Diversity, Equity and Inclusion (DE&I) goals, click here. 

Download the full Corporate Citizenship Report and learn more about Cardinal Health’s corporate citizenship efforts here.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in more than 35 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.

Contacts
Media: Erich Timmerman, [email protected] and (847) 887-1487
Investors: Kevin Moran, [email protected] and (614) 757-7942

Cautions Concerning Forward-Looking Statements
This new release contains forward-looking statements addressing expectations, prospects, estimates and other matters with respect to our environmental, social and governance (ESG) related actions and initiatives that are dependent on future events or developments.  These statements may be identified by words such as “expect,” “anticipate,” “aim,” “intend,” “plan,” “believe,” “will,” “should,” “could,” “would,” “positioned,” “project,” “continue,” “likely,” “commit to” or other words or expressions of similar meaning, although not all forward-looking statements contain such terms.  Actual results may differ materially from those projected, anticipated or implied in forward-looking statements due to a variety of factors, including the risks and uncertainties described in our Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. Forward-looking statements in this report may include, without limitation, statements regarding: (i) strategies for implementing ESG-related programs and related plans, targets, and goals; (ii) commitments to climate-related programs and policies; (iii) expectations and priorities for ESG-related initiatives; and (iv) future ESG reporting.  This release reflects management’s views as of September 20, 2021.  Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statement.  Forward-looking statements are aspirational and not guarantees or promises that goals, targets, or projections will be met, and no assurance can be given that any commitment, expectation, initiative, or plan in this report can or will be achieved or completed.  Investors are cautioned not to place undue reliance on any forward-looking statements. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-establishes-goal-to-reduce-scope-1-and-scope-2-greenhouse-gas-emissions-50-by-2030-301380343.html

SOURCE Cardinal Health

DALLAS, Sept. 20, 2021 /PRNewswire/ — Texas Instruments (TI) (Nasdaq: TXN) today announced its gallium nitride (GaN) technology and C2000™ real-time microcontrollers (MCUs) are being combined with Delta Electronics’ high-efficiency power electronics expertise in the design of an enterprise server power-supply unit (PSU) featuring an 80% improvement in power density with 1% better efficiency — up to 99.2% — for data center applications, compared to enterprise server power supplies using a traditional architecture. A 1% improvement equals 1-megawatt (or 800 households) total cost of ownership savings per data center, according to Energy Innovation¹.

Delta Electronics, a global leader in power- and thermal-management solutions and a leading AC/DC, DC/DC and DC/AC power systems provider for a wide range of applications — including IT, electric vehicle charging, appliances and industrial power — chose TI due to its decade-long investment in GaN technology as well as its real-time control solution with C2000 MCUs. TI uses innovative semiconductor manufacturing processes to manufacture GaN-on-silicon technology and integrated circuits (ICs) to help companies such as Delta Electronics create differentiated applications to more efficiently power data centers around the world.

“Our passion at TI is to create a better world by making electronics more affordable through semiconductors, and our GaN technology enables a whole new world of higher efficiency and smaller, more reliable solutions,” said Steve Lambouses, vice president for High Voltage Power at TI. “In addition to technology investments, TI’s investments in internal manufacturing will allow new technologies like GaN to scale quickly and support customers like Delta.”  

“Delta’s long-term focus on reducing mankind’s carbon footprint through energy-efficient products and solutions entails long-term collaboration with industry leaders such as TI in regards to next-generation technologies. GaN has crossed the threshold from being a future technology to an immediate, viable option available today for new designs of power supply systems,” said Jimmy Yiin, vice president and general manager of the Power and System Business Group at Delta Electronics. “This is especially true for server PSUs, for which we are looking to exceed 98% efficiency and 100 W/inch³ of power density. The next several years will be exciting because GaN will revolutionize power design and architectures as we know them, which will enable Delta to further cement its position as a leading provider of energy-saving solutions for data centers and other major applications.”

Integrated GaN ICs deliver higher efficiency, power density and system reliability

• In high-voltage, high-power industrial applications, integrated power-supply solutions are better able to achieve high performance within limited board space. TI GaN field-effect transistors (FETs) integrate a fast-switching driver, plus internal protection and temperature sensing.
• These ICs are backed by more than 40 million hours of device reliability testing and more than 5 GWh of power conversion testing, providing rigorous reliability data to support engineers who want to consider GaN to build power systems that are smaller, lighter and more efficient.
• When coupled with TI GaN power solutions, TI C2000 real-time MCUs deliver benefits such as complex, time-critical processing, precision control, and software and peripheral scalability. Additionally, these MCUs fully unlock the potential of GaN-based power solutions for server PSUs by supporting different power-design topologies and high switching frequencies to maximize the design’s power efficiency.

Manufacturing and long-term investment strategy offer volume scalability

• TI’s unique combination of process, package and circuit-design techniques simplifies manufacturing and enables the company to scale GaN-on-silicon production volume by configuring different options to support the changing needs of telecom, industrial and automotive companies.
• TI’s wholly owned GaN epitaxy and assembly/test footprint enables the company to address tool redundancies, as required.
• TI’s long-term investment and flexible manufacturing strategy will allow the company to grow as a leading GaN and real-time MCU supplier, as market demand increases and the trend continues toward smaller systems supporting more data.

TI and Delta Electronics will co-present an “industry insight” session — “The Impact of GaN Technology and What It May Mean for Future Industrial Designs” — during the TI Live! Tech Exchange virtual event, Sept. 27-29, 2021. During the event, TI experts will discuss power management, automotive, real-time control, vision sensing and design trends in a series of keynotes, roundtable discussions, technical sessions and demonstrations. Learn more at ti.com/techexchange. 

For more information, see TI.com/gan.

¹ Energy Innovation, “How Much Energy Do Data Centers Really Use?”, March 17, 2020.

About Texas Instruments
Texas Instruments Incorporated (Nasdaq: TXN) is a global semiconductor company that designs, manufactures, tests and sells analog and embedded processing chips for markets such as industrial, automotive, personal electronics, communications equipment and enterprise systems. Our passion to create a better world by making electronics more affordable through semiconductors is alive today, as each generation of innovation builds upon the last to make our technology smaller, more efficient, more reliable and more affordable – making it possible for semiconductors to go into electronics everywhere. We think of this as Engineering Progress. It’s what we do and have been doing for decades. Learn more at TI.com.

Trademarks
C2000 is a trademark of Texas Instruments. All registered trademarks and other trademarks belong to their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ti-brings-the-power-of-gan-technology-to-delta-electronics-energy-efficient-server-power-supplies-for-data-centers-301379998.html

SOURCE Texas Instruments

SANTA CLARA, Calif., Sept. 20, 2021 /PRNewswire/ — Today eHealth, Inc. (NASDAQ: EHTH) (eHealth.com) announced that Christine Janofsky has joined its leadership team on September 20^th as senior vice president, chief financial officer. In her new role, she will oversee all aspects of finance including financial strategy, planning and analysis, accounting, tax and treasury. With the addition of Ms. Janofsky, 23% eHealth’s senior vice presidents and 31% of its vice presidents are women. John Pierantoni, who served as the company’s interim principal financial officer, will remain its chief accounting officer.

Ms. Janofsky brings more than 20 years of finance and insurance experience to eHealth, most recently serving as senior vice president and chief accounting officer at Lincoln Financial Group since 2016, leading the company’s FP&A, transformation, consolidated financial reporting, reinsurance, investment, and tax functions. Ms. Janofsky also led the working group for diversity and inclusion within the corporate finance team. Prior to joining Lincoln Financial Group, Ms. Janofsky served as vice president of finance at Fidelity & Guaranty Life and in various senior finance leadership roles, with Nationwide Insurance.

“The board and I are delighted to have Christine join eHealth as she is a highly respected finance executive whose leadership and operational rigor will be critical for the company as we enter our next phase of growth,” said eHealth CEO Scott Flanders. “The company is at an inflection point as consumers increasingly turn to our tech-enabled online platform to enroll in health insurance plans. Christine’s experience and insights will be instrumental in better serving our beneficiaries, and in turn, our shareholders.”

“eHealth is setting the standard for how beneficiaries research, select, and enroll in Medicare plans best suited to their personal needs,” said Christine Janofsky. “It’s an exciting market with incredible growth potential. I look forward to joining eHealth’s leadership team and contributing to the company’s future success.”

About Christine Janofsky

Prior to joining eHealth, Ms. Janofsky served as senior vice president and chief accounting officer at Lincoln Financial Group. Prior to joining Lincoln, Ms. Janofsky served in various senior finance leadership roles in the financial organizations of F&G, Nationwide Insurance, and L Brands. Ms. Janofsky is a member of World 50, a community for executives at globally respected organizations to discover innovative ideas, share valuable experiences and build relationships that make a lasting impact. Ms. Janofsky has received both the CPA and CGMA designations.

About eHealth

eHealth, Inc. (NASDAQ: EHTH) operates a leading health insurance marketplace at eHealth.com and eHealthMedicare.com with technology that provides consumers with health insurance enrollment solutions. Since 1997, we have connected more than 8 million members with quality, affordable health insurance, Medicare options, and ancillary plans. Our proprietary marketplace offers Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual, family, small business and other plans from over 200 health insurance carriers across 50 states and the District of Columbia.

Media inquiries: 
[email protected]

Investor Relations Contact:

Kate Sidorovich, CFA
Senior Vice President, Investor Relations & Strategy
650-210-3111
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/ehealth-appoints-christine-janofsky-as-chief-financial-officer-301380277.html

SOURCE eHealth, Inc.

SAN FRANCISCO, Sept. 20, 2021 /PRNewswire/ — Twitter, Inc. (NYSE: TWTR) today announced that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. The case was consolidated under the caption In re Twitter, Inc. Securities Litigation, Case No. 4:16-CV-0534-JST (SK). 

The proposed settlement resolves all claims asserted against Twitter and the other named defendants without any admission, concession or finding of any fault, liability or wrongdoing by the Company or any defendant. Twitter and the individual defendants continue to deny any wrongdoing or any other improper actions. 

Under the terms of the proposed settlement, Twitter will pay $809.5 million for claims alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The Company intends to use cash on hand to pay the settlement amount, which is expected to be paid in the fourth quarter of 2021. The Company expects to record a charge for the settlement during the third quarter of 2021. 

The final settlement agreement will be subject to approval by the Court. 

About Twitter, Inc. 

Twitter (NYSE: TWTR) is what’s happening and what people are talking about right now. To learn more, visit about.twitter.com and follow @Twitter. Let’s talk.

Contacts 

Investors: 
[email protected] 

Press: 
[email protected]

View original content:https://www.prnewswire.com/news-releases/twitter-announces-proposed-settlement-of-consolidated-class-action-lawsuit-301380355.html

SOURCE Twitter, Inc.